Abstract-The effect of (-{-) INPEA on various stimulant drugs was examined on isolated rat uterus. Addition of (;) INPEA (1 > 10-5 g/ml) to the organ bath, pro duced marked potentiation in the contractile responses of oxytocin and prostaglan dins. Potentiation was less significant to 5-HT, vasopressin, angiotensin and brady kinin. (-) INPEA did not potentiate the responses of oxytocin on isolated rat mam mary strip and the responses of prostaglandins on rat stomach (fundus) strip, guinea pig tracheal chain and guinea-pig ileum. The significance of these findings has been discussed.
(_') INPEA (1-4'-nitrophenyl-2-isopropyl aminoethanol) hydrochloride, an adre nergic beta receptor blocking agent has been clinically evaluated in angina pectoris and cardiac arrhythmias and was shown to be effective (1, 2) . Its beta blocking effect has been reported to be considerably less than the reference beta blocker, propranolol (3) .
While studying the pharmacological properties of INPEA, Saini and Sharma (4) observed a marked difference in the pharmacological activity between its optical isomers. Both (-) INPEA and (H-) INPEA exhibited weak antioxytocin activity. In contrast, (+) INPEA produced a marked potentiating effect of oxytocin-evoked responses. In sub sequent studies, (H-) INPEA also markedly potentiated prostaglandins-evoked responses of isolated rat uterus (5) . Recently, a significant sensitization to oxytocin and prosta glandins-evoked responses was observed in uteri of rats pretreated with (+) INPEA (6) .
In the present study' a number of uterine stimulants and a number of tissues respon sive to oxytocin or prostaglandins were used to investigate the specificity and selectivity respectively, if any, of the (=) INPEA-induced potentiation.
MATERIALS AND METHODS

Specificity of (-'-) INPEA-induced potentiation
The potentiating effect of (-!-) INPEA on the contractile responses evoked by various agonists was studied on isolated rat uterus preparation, as described by Holton (7) . Oest rus induced rats (oestradiol dipropionate 200 ,ug, s.c., 15 hr prior to starting the experiment)
of Charles-Foster strain weighing 150-200 g were used. The animals were stunned by a blow on the head and a small piece (2 cm) of the cervical end of the uterine horn was re moved and suspended in an organ bath (10 ml) containing de Jalon's solution (9 g NaCI, 0.42 g KCI, 0.06 g CaC12.2H2O, 0.5 g glucose, I g NaHCO3, 0.05 g NaH2PO4, distilled water added to make 1000 ml., all reagents A.R.) at 29°C which was aerated through an air pump (C.F. Palmer, London; Model ES-ES). The contractions were recorded on a Servoscribe potentiometric recorder (Smiths Industries Ltd., model RE 511.20) using a force displacement transducer (Grass Instrument Co. FT-03). The resting tension on the tissue was 0.5 g. An equilibration period of 30 min was allowed before the addition of drugs. After stabilization, no spontaneous change in excitability of uterine tissue was noticed in control experiments over an observation period of 120 minutes.
Once the tissue was stabilized, control responses to (A) a single dose and (B) graded doses of each of the agonists were obtained at intervals of five minutes. The drug was allowed to be in contact with the tissue for 45 sec and two changes in the bath fluid were made with fresh de Jalon's solution in the intervals between doses. While taking re sponses for a single dose, to avoid approximation of the potentiated response to the maxi mal response, the dose which gave the minimal detectable response was selected for each drug. For obtaining the dose-response, graded doses were continued until the maximal response was reached. After obtaining control responses, (-) INPEA (I x 10 g/ml) was added to the de Jalon's solution and allowed to act for 30 min after which time the doses of the agonists were repeated. At this concentration (based on preliminary experiments), (+) INPEA did not, per se, induce spontaneous contractions and also produced a maximall effect on oxytocin and prostaglandins-evoked contractions. The various agonists used were: oxytocin, prostaglandins (PGE1, PGE2 and PGF2,r), vasopressin, angiotensin, 5 HT and bradykinin.
From the tracings obtained in the above experiments, (-L) INPEA-induced potentia tion was analysed by measuring the heights of contractions before and after (-f ) INPEA with each of the agonists studied. In the experiments wherein the maximal responses were obtained with each agonist, log-dose response curves were constructed and ED50
(the effective molar concentration of the drug necessary to produce 50% of the maximal response) values were determined and the values obtained were compared before and after the addition of (--) INPEA.
Selectivity of (_-) INPEA-induced potentiation
Experiments were carried out on the following preparations to ascertain whether (' -) INPEA-induced potentiation is selective only for the uterine tissue or is non-selective and occurs in other tissues as well. The most specific agonist for that particular tissue was used in these experiments.
Isolated strip of rat rnaimnary gland: The method of Reyden and Sjoholm (8) was followed. Lactating rats (3-10 days after delivery of litters) were sacrificed and one of the lower mammary glands was removed. A strip (3 cm x 0.5 cm x 0.5 cm) was suspended in a 10 ml organ bath at 38°C containing Tyrode's solution (NaCI 8g, KCI 0.2 g, CaC12 0.15 g, NaHCO3 I g, glucose I g, MgCI2 0.1 g, NaH2PO4 0.05 g, distilled water added to make 1000m]). The solution was saturated with a mixture of 95% 02 and 5 ;0 CO2. A 0.5 g tension was applied to the tissue and an equilibration period of one hr was allowed before the addition of drugs.
Contractions evoked by the graded doses of oxytocin were recorded at intervals of 10 min by a potentiometric recorder. The drug was allowed to be in contact with the tissue for 60 sec and two changes of the bath fluid were made in the intervals between doses.
After obtaining the control responses, ( ) INPEA (1 -. 10-s g;'ml) was added to the bath fluid and allowed to act for 30 min after which time the doses of oxytocin were re peated. Log-dose response curves were constructed and a change in the ED50 value pro duced by ( ) INPEA was noted.
Isolated stomach (fundus) strip of rat:
The method used was that of Vane (9) . Rats which were fasted overnight were sacrificed and the fundic part of the stomach was re moved. The tissue was transferred to a dish containing Kreb's solution (NaCI 5.54 g, KCI 0.5 g, MgSO4.7H2O 0.2 g, CaC12.2H2O 0.28 g, KH2PO4 0.16 g, NaHCO3 2.1 g, glu cose 2.1 g, distilled water added to make 1000 ml). A 4.5 cm long strip was made from each of the stomachs by suitable transverse cuts and suspended in an organ bath (10 ml) containing Kreb's solution at 37'C and was aerated through Palmer's aeration pump. A resting tension of I g was applied to the tissue.
After an equilibration period of 1 hr, responses to graded doses of PGE, were taken at intervals of 15 min on a slowly moving smoked drum using an isotonic lever which gave an 8 fold magnification. The drug was allowed to be in contact with the tissue for 60 sec and at least two changes in the bath fluid were made in the intervals between doses. Log-dose responses were constructed and the change in the ED50 value produced by (a ) INPEA was noted.
Isolated guinea pig ileum:
The method used was that of Magnus (10) . Adult gui nea-pigs weighing above 300 g were sacrificed and a small piece (3-4 cm) of ileum was sus pended in the isolated bath. of 10 ml capacity filled with Tyrode's solution at 37'C and was aerated. A resting tension of 0.5 g was applied to the tissue. After an equilibra tion period of 1 hr, responses evoked by the graded doses of PGE2 were recorded on a potentiometric recorder.
The drug was allowed to be in contact with the tissue for 30 sec and a 15 min interval between doses followed to avoid any possibility of developing tachyphylaxis. At least two changes in the bath fluid were made in the intervals between doses.
After obtaining the control responses of PGE2, (!-) INPEA (1 >: 10-s g/ml) was then added to the bath fluid and allowed to act for 30 min after which time the same doses of PGE2 were repeated. Log-dose response curves were plotted and the change in the ED50 value produced by (-i ) INPEA was noted.
Isolated guinea-pig tracheal chain:
The method of Castillo and de Beer (11) was followed. Adult guinea-pigs were sacrificed and the trachea was dissected and trans ferred to a dish containing Kreb's solution.
The trachea was then sectioned into rings by cutting transversely between the segments of the cartilege. Six to seven rings were tied together to form a chain with the muscular part of the rings arranged alternately.
The chain thus prepared was suspended in an organ bath (10 ml), containing Kreb's solution at 37'C which was saturated with a mixture of 95 % 02 and 5 CO2. An initial to graded doses of PGF2" were taken at intervals of 15 min on a smoked drum using a straw lever which gave an 8 fold magnification. The drug was allowed each time to be in contact with the tissue for 60 sec and at least two washings were made in the intervals between doses. After obtaining control resopnses to PGF2,1 (') INPEA (1 l0-s giml) was ad ded to the bath fluid and allowed to act for 30 min after which time the doses of PGF2" were repeated. Dose-response curves were plotted and the shift in the curve produced by Stock solutions of prostaglandins were prepared in phosphate buffer (pH 7.4). Fur ther dilutions were made in 0.9",', sodium chloride. All other drugs were prepared in the appropriate bath fluid immediately before use. Statistical analysis: Levels of signifi cance were calculated using Student's t-test.
RESULTS
Specificity, of ( ) IXPE.4-induced potentiation
The results obtained are summarized in Fig. I and Table 1 . Oxytocin (25 /tU/ml), PGE, (10 ng;'ml ), PG E2 (10 ng'nil ), PGF2,, (5 ng'ml ), vasopressin (0.5 mU/ml ), angiotensin (Fig. 2) . The results were not statistically significant (P>0.05). Isolated stomach (fundus) strip of rat: Sensitivity of the rat stomach strip was very high to PGEI (0.1 ng/ml) and the responses obtained were dose related. There was a slight shift to the left of the log-dose response curve of PGEI after the addition of (--)
INPEA (1 x 10-s g/ml) to the organ bath (Fig. 3) . The apparent potentiation was, how ever, not significant (P>0.05).
Isolated guinea pig ileum: Guinea-pig ileum responded to doses of PGE2 from 5 ng/ml onwards and maximal response could be obtained with graded doses. No tachy phylaxis was observed. Addition of (+) INPEA (1 x 10-s g/ml) to the organ bath signifi cantly (P<0.01) inhibited the responses of PGE2. The log-dose response curve was shifted to the right in the presence of (~ ) INPEA in the bath fluid (Fig. 4) . The maximal response could not be obtained.
smooth muscle of guinea-pig tracheal chain with graded doses of PGF2,,. Addition of (--) IN PEA (1 x 10-5 g/ml) to the bath fluid produced a weak inhibitory effect on the re sponses evoked by PGF2 and showed a shift to the right of the dose-response curve. The changes observed were, however, statistically not significant (P>0.05).
DISCUSSION
The results obtained in the present study reveal certain differences in the sensitivity patterns of rat uterus to various agonists. Among the prostaglandins, rat uterus was rather more sensitive to PGF2,X than PGE1. Similar observations have been made by Horton and Main (12) (Table 11 ). The reduction in the ED50 values was more significant for oxytocin and prostaglandins. The order of potentiation was El, E2, F2a, oxytocin, vasopressin --bradykinin, angiotensin, 5-HT (Table 11) . (--) INPEA-induced potentiation appears to be selective for the uterine muscle. Studies made with 3H-oxytocin revealed that the receptor sites were different for oxytocin and prostaglandins in the uterine muscle (14) . In the present study, (-, ) INPEA poten tiated both oxytocin and prostaglandins-evoked responses on this tissue. ( ) INPEA did not potentiate the oxytocin-evoked responses of isolated rat mammary strip. The reason for (-) INPEA not being able to potentiate the response of mammary gland to oxy tocin could be that the receptors may be present within the cell and not on the membrane and the drug is somehow not able to reach the receptor site.
Similarly PGF2«-evoked responses of gut and tracheal smooth muscle were not poten tiated by (}-) INPEA. This shows that the receptors present in these tissues may be dif ferent and it has been suggested that these are unlikely to exist as a single receptor, in view of the differences between prostaglandins and the multiplicity of their actions on different systems (15) . On intestinal and bronchial smooth muscles ,(-) INPEA ex hibited a considerable inhibitory effect on prostaglandin-evoked responses. A similar inhibitory effect was also noticed on these tissues to the contractile effects of histamine and acetylcholine after (-) INPEA (unpublished observations) indicating a non-specific action.
Murmann (personal communication) indicated that (=) INPEA did not produce toxic effects on acute tests on mice and rats, and in chronic studies rats, dosed orally for 180 days. The drug also appears to be well tolerated in human subjects. A single oral dose (700 mg) and a single intravenous dose (75 mg) did not produce any untoward effect in hypertensive patients (16) . However, pharmacological studies in human subjects are very few since (-) INPEA lacks practically any important blocking activity on beta ad renoceptors. The therapeutic results were not encouraging and clinical studies were not pursued.
Many side-effects have been observed with the clinical use of oxytocin and prosta glandins when used for induction of labour or therapeutic abortion. Severe water intoxication has been reported when oxytocin was used to terminate pregnancy (17) (18) (19) (20) . The use of prostaglandins for induction of labour and abortion has also been associated with undesirable side-effects, viz. nausea, vomiting, diarrhoea, fever, phlebitis and bron choconstriction (21) (22) . At high dose levels, with prostaglandins in particular, the side effects are distressing, while, at the lower levels, failures and incomplete abortions neces sitating surgical intervention increase significantly. It is evident from the present study that (-) INPEA more or less specifically poten tiated oxytocin and prostaglandins-evoked responses of the uterine muscle. In view of this and its relative safety for clinical use, a combination of (--) INPEA with either oxy tocin or prostaglandins or even with both may permit the use of smaller doses of oxytocin and prostaglandin when used for induction of labour or therapeutic abortion, thereby, limiting their side-effects and at the same time increasing their therapeutic efficacy.
